WO2000063697A1 - Device for the testing of fluid samples and process for making the device - Google Patents
Device for the testing of fluid samples and process for making the device Download PDFInfo
- Publication number
- WO2000063697A1 WO2000063697A1 PCT/US2000/008736 US0008736W WO0063697A1 WO 2000063697 A1 WO2000063697 A1 WO 2000063697A1 US 0008736 W US0008736 W US 0008736W WO 0063697 A1 WO0063697 A1 WO 0063697A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- test
- card
- test card
- test strips
- multiple drug
- Prior art date
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 229
- 238000000034 method Methods 0.000 title claims abstract description 16
- 230000008569 process Effects 0.000 title claims abstract description 13
- 239000012530 fluid Substances 0.000 title claims description 13
- 239000003814 drug Substances 0.000 claims abstract description 50
- 229940079593 drug Drugs 0.000 claims abstract description 49
- 238000003255 drug test Methods 0.000 claims abstract description 22
- 238000003018 immunoassay Methods 0.000 claims abstract description 12
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 239000011888 foil Substances 0.000 claims description 3
- 230000000007 visual effect Effects 0.000 abstract description 8
- 238000001514 detection method Methods 0.000 abstract description 4
- 230000004044 response Effects 0.000 abstract description 2
- 210000002700 urine Anatomy 0.000 description 18
- 238000012986 modification Methods 0.000 description 13
- 230000004048 modification Effects 0.000 description 13
- 239000007787 solid Substances 0.000 description 9
- 206010013654 Drug abuse Diseases 0.000 description 7
- 238000003677 abuse test Methods 0.000 description 7
- 208000011117 substance-related disease Diseases 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/525—Multi-layer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
Definitions
- the present invention relates to the collection and testing of fluid samples for drugs of abuse, more particularly, to a multiple drug test card for indicating visually the presence of particular drugs of abuse in urine and a process for making the test card.
- test apparatus must be such so as
- test card having a plurality of immunoassay test strips on one or both sides thereof with each
- test card
- abuse test device which may comprise a cup-like transparent container for retaining a urine sample to be tested.
- the open top of the container has
- the slit is of such a size to accommodate a test card
- each test strip is
- test card is
- a second closure cap which is solid, i.e., not slit, is provided which may be threaded into the open end of the cup-like container. The test card is removed from the
- the solid closure cap is threaded on to close the
- test kit includes a drug abuse test device for collecting and testing a urine sample.
- test device comprises a cup-like container having a substantially
- Fig. 1 is a perspective view of the drug abuse test kit according to the present invention generally showing the
- test card partially inserted to the testing
- Fig. 2 is an exploded perspective view of the container
- Fig. 3 is a plan view of the test side of a test card
- Fig. 4 is a plan view of the reverse side of the test
- Fig. 5 is an end elevational view of the test card shown
- Fig. 6 is a sectional view taken along the line VI-VI of
- Fig. 7 is a plan view of the opened two piece test card
- Fig. 8 is a plan view of another modification of the test card
- Fig. 10 is a plan view of the test side of a further modification of the test card
- Fig. 11 is a plan view of the center ply of the test card
- Fig. 12 is a plan view of the reverse side of the test
- Fig. 13 is a sectional view taken along the line XIII-
- Fig. 16 is an end view of the test card shown in Fig. 10;
- Fig. 17 is a plan view of a further modification of the
- Fig. 18 is a plan view of the reverse side of the test
- Fig. 19 is an end view of the test card of Fig. 17;
- Fig. 20 is a sectional view taken along the line XX-XX of
- Fig. 21 is a side elevational view of the test card of Fig. 17.
- Figs. 22-24 are plan views of further modifications of
- Fig. 25 is a schematic view illustrating the assembly of
- Fig. 26 is a plan view of a foil pouch with a test card
- a drug abuse test kit As may be seen in Figs. 1 and 2, a drug abuse test kit
- the cylindrical wall 12 may have a slight
- the open end 14 of the test cup 11 is provided with
- the cover 22 has a circular top surface 23 from the periphery of which depends a
- the cover surface 23 has a
- the cover 22 but is solid or unslit so that the covers 15 and
- test cup 11 The cover 15 is generally
- the cup container is essentially a specimen cup as
- the container may be formed or molded from any suitable material,
- a transparent wall is not necessary and the wall may be translucent or even opaque. It is sufficient that the material
- test strips through the wall of the container when the test
- test card 25 which will indicate the presence or
- test card is of the
- Test strips 26-30 may be of the type as made by Bionike of
- test strips are characterized as immunoassay strips and employ colloidal gold chemistry. Each test strip is submerged
- test area indicates "negative" or the absence of the test
- test strips may be completely recessed as shown in
- the test card may b e formed of two plys 34 and 35 as may be seen in Fig. 7 and these plys in turn are formed from a single strip having a bend or fold 36.
- the ply 35 is formed with a plurality of die cut slots 37 which are shaped and sized to receive each of the test strips.
- portions 34 and 35 are folded over at end 36 and are adhered
- test strips are then placed into the slots as
- the cap 22 is provided with a readily removable adhesive sealing strip 18 which is placed over the slit 19.
- the protective strip 18 is
- test card is inserted into the slit until the bottom of the test card
- test can be read on each individual test strip through the test
- test card A modification of the test card is shown at 44 in Fig. 8.
- the test card 44 comprises a
- test strips and slots are provided in the center ply to
- the top and bottom faces of the central ply 45 are covered by a bottom ply 46 and a top ply 47
- top and bottom plys may
- the top ply 47 is provided with a plurality of test windows 50
- sample openings 51 are provided.
- sample openings 51 through which the liquid test
- the bottom and top plys 46 and 47 are then laminated.
- the bottom and top plys 46 and 47 are then laminated.
- the center ply 45 is made of styrene having a thickness of
- the top ply 47 similarly has the test openings
- the central ply 45 is provided with a plurality of longitudinally extending slots 52 and a test strip 53 is
- test card has provision
- windows 50 and 51 for the omitted strips are usually solid.
- Test card 54 has a front face or surface 55
- reverse side of the test card may vary as shown in the rear
- the test card 54 has the front and back plys or faces 55
- slots 52 in the intermediate plys may be assembled with a test
- test strips would be assembled in intermediate ply 62 to
- the front panel 55 is provided with a plurality of test
- openings 64 are positioned to correspond with
- the central ply 60 is imperforate so as to maintain
- the template 68 may have one .or more
- the back panel 46 may be positioned in the
- the central panel will have the longitudinally extending side-by-side parallel slots therein and an immunoassay test strip is then positioned in one or more of these slots.
- the front panel 55 is then positioned over the middle or center panel 45 to enclose the test strips therein.
- the front panel 55 has the appropriate test window 63 and sample receiving window 64 therein as described above. The assembled test card having test strips on one face thereof is then removed from
- test card such as illustrated in Figs. 18 and 22-24
- the assembled test card as described above is turned over and repositioned in the recess so that the front face or panel 55 is seated in the template. Subsequently, a second middle or central ply 45 which has adhesive on both faces thereof is positioned
- test card such as 54 shown in Fig. 26 is
- test strips 26-30 and 53 is a one-step
- the test strip consists of a membrane strip onto which a drug conjugate has been immobilized.
- reaction occurs forming a visible line in the test area.
- the formation of a visible line in the test area occurs when the
- the drug or its metabolite will compete with the immobilized drug conjugate in the test area for the limited antibody sites on the colloidal gold-labeled antibody complex. If a sufficient amount of drug is present, it will fill all of the available binding sites, thus preventing attachment of the label antibody to the drug conjugate. An absence of a color line or band in the test area is indicative
- a control band or line comprised of a different antibody/antigen reaction is present on the membrane strip.
- the control line is not influenced by the presence or absence of drug in the urine and therefore should be present in all reactions .
- test card can also be used as a carrier or delivery
- a novel and improved drug abuse test kit which comprises a
- test card through the wall of the container.
- the test card thus comprises a number of individual test strips of the
- test card may be made of plastic coated cardboard or thin sheets of plastic which are laminated together. This drug abuse test kit enables one to
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14023000A IL140230A0 (en) | 1999-04-21 | 2000-04-19 | Device for the testing of fluid samples and process for making the device |
GB0028544A GB2354320A (en) | 1999-04-21 | 2000-04-19 | Device for the testing of fluid samples and process for making the device |
CA002334802A CA2334802C (en) | 1999-04-21 | 2000-04-19 | Device for the testing of fluid samples and process for making the device |
EP00923112A EP1088230A4 (en) | 1999-04-21 | 2000-04-19 | Device for the testing of fluid samples and process for making the device |
AU43291/00A AU4329100A (en) | 1999-04-21 | 2000-04-19 | Device for the testing of fluid samples and process for making the device |
BR0006069-0A BR0006069A (en) | 1999-04-21 | 2000-04-19 | Test card for multiple drugs for testing fluid samples and process to produce it |
HU0102458A HUP0102458A2 (en) | 1997-11-05 | 2000-04-19 | Device for the testing of fluid samples and process for making the device |
NO20006492A NO20006492L (en) | 1999-04-21 | 2000-12-19 | Device for testing fluid samples and method for making the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98166597A | 1997-11-05 | 1997-11-05 | |
US09/295,095 US6372515B1 (en) | 1996-03-11 | 1999-04-21 | Device for the testing of fluid samples and process for making the device |
US09/295,095 | 1999-04-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000063697A1 true WO2000063697A1 (en) | 2000-10-26 |
WO2000063697A9 WO2000063697A9 (en) | 2002-01-24 |
Family
ID=26968917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/008736 WO2000063697A1 (en) | 1997-11-05 | 2000-04-19 | Device for the testing of fluid samples and process for making the device |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP0102458A2 (en) |
WO (1) | WO2000063697A1 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2377016A (en) * | 2001-06-28 | 2002-12-31 | Surescreen Diagnostics Ltd | Test strips for determining analytes in a fluid |
WO2003086200A1 (en) * | 2002-04-08 | 2003-10-23 | Varian, Inc. | Disk testing apparatus |
WO2005031355A1 (en) * | 2003-09-22 | 2005-04-07 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
GB2410087A (en) * | 2003-12-19 | 2005-07-20 | Bloomsbury Innovations Ltd | Multiple drug assay kit for testing beverages |
WO2006118622A1 (en) * | 2005-04-29 | 2006-11-09 | Kimberly-Clark Worldwide, Inc. | Metering technique for lateral flow assay devices |
US7438852B2 (en) | 2003-11-14 | 2008-10-21 | Inverness Medical Switzerland Gmbh | Sample collection cup with integrated sample analysis system |
US7550112B2 (en) | 2003-11-14 | 2009-06-23 | Oakville Hong Kong Company Limited | Sample collection cup with integrated activatable sample analysis system |
US7790471B2 (en) | 2005-12-13 | 2010-09-07 | Kimberly-Clark Worldwide, Inc. | Metering technique for lateral flow assay devices |
US7794656B2 (en) | 2006-01-23 | 2010-09-14 | Quidel Corporation | Device for handling and analysis of a biological sample |
US7838258B2 (en) | 2005-12-14 | 2010-11-23 | Kimberly-Clark Worldwide, Inc. | Meter strip and method for lateral flow assay devices |
US7858384B2 (en) | 2005-04-29 | 2010-12-28 | Kimberly-Clark Worldwide, Inc. | Flow control technique for assay devices |
US7871568B2 (en) | 2006-01-23 | 2011-01-18 | Quidel Corporation | Rapid test apparatus |
WO2013001102A1 (en) * | 2011-06-27 | 2013-01-03 | V.P. Pharma Baru, S.L. | System for detecting commonly abused drugs |
US8535617B2 (en) | 2007-11-30 | 2013-09-17 | Kimberly-Clark Worldwide, Inc. | Blood cell barrier for a lateral flow device |
US8563317B2 (en) | 2004-03-12 | 2013-10-22 | Bloomsbury Innovations Ltd. | Apparatus for detecting gamma hydroxybutyrate, ketamines and related drugs in beverages |
US9011770B2 (en) | 2005-10-25 | 2015-04-21 | Alere Switzerland Gmbh | Device for detecting analytes in fluid samples |
WO2021017417A1 (en) * | 2019-07-30 | 2021-02-04 | 南通伊仕生物技术股份有限公司 | Human chorionic gonadotropin semi-quantitative detection test paper and preparation method therefor, human chorionic gonadotropin semi-quantitative detection reagent cup, and applications thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4518565A (en) * | 1983-06-06 | 1985-05-21 | Miles Laboratories, Inc. | Reagent test device holder |
US5119830A (en) * | 1991-04-03 | 1992-06-09 | Code Blue Medical Corporation | Analytical specimen cup with testing means |
US5238652A (en) * | 1990-06-20 | 1993-08-24 | Drug Screening Systems, Inc. | Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques |
US5500375A (en) * | 1993-04-13 | 1996-03-19 | Serex, Inc. | Integrated packaging-holder device for immunochromatographic assays in flow-through or dipstick formats |
WO1997033519A1 (en) * | 1996-03-11 | 1997-09-18 | American Bio Medica Corporation | Device for the collection, testing and shipment of body fluid samples |
US5807752A (en) * | 1992-09-11 | 1998-09-15 | Boehringer Mannheim Corporation | Assay using an unblocked solid phase with immobilized analyte binding partner |
-
2000
- 2000-04-19 HU HU0102458A patent/HUP0102458A2/en unknown
- 2000-04-19 WO PCT/US2000/008736 patent/WO2000063697A1/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4518565A (en) * | 1983-06-06 | 1985-05-21 | Miles Laboratories, Inc. | Reagent test device holder |
US5238652A (en) * | 1990-06-20 | 1993-08-24 | Drug Screening Systems, Inc. | Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques |
US5119830A (en) * | 1991-04-03 | 1992-06-09 | Code Blue Medical Corporation | Analytical specimen cup with testing means |
US5807752A (en) * | 1992-09-11 | 1998-09-15 | Boehringer Mannheim Corporation | Assay using an unblocked solid phase with immobilized analyte binding partner |
US5500375A (en) * | 1993-04-13 | 1996-03-19 | Serex, Inc. | Integrated packaging-holder device for immunochromatographic assays in flow-through or dipstick formats |
WO1997033519A1 (en) * | 1996-03-11 | 1997-09-18 | American Bio Medica Corporation | Device for the collection, testing and shipment of body fluid samples |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2377016A (en) * | 2001-06-28 | 2002-12-31 | Surescreen Diagnostics Ltd | Test strips for determining analytes in a fluid |
WO2003086200A1 (en) * | 2002-04-08 | 2003-10-23 | Varian, Inc. | Disk testing apparatus |
US7691644B2 (en) | 2003-09-22 | 2010-04-06 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
WO2005031355A1 (en) * | 2003-09-22 | 2005-04-07 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
US8722426B2 (en) | 2003-09-22 | 2014-05-13 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
US10415104B2 (en) | 2003-09-22 | 2019-09-17 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
US7378285B2 (en) | 2003-09-22 | 2008-05-27 | Paul Lambotte | Devices for the detection of multiple analytes in a sample |
US9207241B2 (en) | 2003-09-22 | 2015-12-08 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
US9797019B2 (en) | 2003-09-22 | 2017-10-24 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
US7438852B2 (en) | 2003-11-14 | 2008-10-21 | Inverness Medical Switzerland Gmbh | Sample collection cup with integrated sample analysis system |
US7550112B2 (en) | 2003-11-14 | 2009-06-23 | Oakville Hong Kong Company Limited | Sample collection cup with integrated activatable sample analysis system |
GB2410087B (en) * | 2003-12-19 | 2008-11-19 | Bloomsbury Innovations Ltd | Drug assay kit for testing beverages |
GB2410087A (en) * | 2003-12-19 | 2005-07-20 | Bloomsbury Innovations Ltd | Multiple drug assay kit for testing beverages |
US8563317B2 (en) | 2004-03-12 | 2013-10-22 | Bloomsbury Innovations Ltd. | Apparatus for detecting gamma hydroxybutyrate, ketamines and related drugs in beverages |
US7803319B2 (en) | 2005-04-29 | 2010-09-28 | Kimberly-Clark Worldwide, Inc. | Metering technique for lateral flow assay devices |
US8124421B2 (en) | 2005-04-29 | 2012-02-28 | Kimberly-Clark Worldwide, Inc. | Flow control technique for assay devices |
CN101166978B (en) * | 2005-04-29 | 2012-06-13 | 金伯利-克拉克环球有限公司 | Metering technique for lateral flow assay devices |
US7858384B2 (en) | 2005-04-29 | 2010-12-28 | Kimberly-Clark Worldwide, Inc. | Flow control technique for assay devices |
WO2006118622A1 (en) * | 2005-04-29 | 2006-11-09 | Kimberly-Clark Worldwide, Inc. | Metering technique for lateral flow assay devices |
US9011770B2 (en) | 2005-10-25 | 2015-04-21 | Alere Switzerland Gmbh | Device for detecting analytes in fluid samples |
US7790471B2 (en) | 2005-12-13 | 2010-09-07 | Kimberly-Clark Worldwide, Inc. | Metering technique for lateral flow assay devices |
US7838258B2 (en) | 2005-12-14 | 2010-11-23 | Kimberly-Clark Worldwide, Inc. | Meter strip and method for lateral flow assay devices |
US7871568B2 (en) | 2006-01-23 | 2011-01-18 | Quidel Corporation | Rapid test apparatus |
US7794656B2 (en) | 2006-01-23 | 2010-09-14 | Quidel Corporation | Device for handling and analysis of a biological sample |
US8535617B2 (en) | 2007-11-30 | 2013-09-17 | Kimberly-Clark Worldwide, Inc. | Blood cell barrier for a lateral flow device |
WO2013001102A1 (en) * | 2011-06-27 | 2013-01-03 | V.P. Pharma Baru, S.L. | System for detecting commonly abused drugs |
WO2021017417A1 (en) * | 2019-07-30 | 2021-02-04 | 南通伊仕生物技术股份有限公司 | Human chorionic gonadotropin semi-quantitative detection test paper and preparation method therefor, human chorionic gonadotropin semi-quantitative detection reagent cup, and applications thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2000063697A9 (en) | 2002-01-24 |
HUP0102458A2 (en) | 2001-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2334802C (en) | Device for the testing of fluid samples and process for making the device | |
EP0830082B1 (en) | Device for the collection, testing and shipment of body fluid samples | |
US6403383B1 (en) | Diagnostic test kit for immunological assays of fluid samples | |
US6406922B2 (en) | Device for the testing of body fluid samples | |
WO2000063697A1 (en) | Device for the testing of fluid samples and process for making the device | |
US6375897B1 (en) | Urine collection cup | |
AU764945B2 (en) | Multiple analyte assay device with sample integrity monitoring system | |
EP0920621B1 (en) | Chromatographic assay or test device | |
US8206661B2 (en) | Assay device and process for the testing of fluid samples | |
EP1018004B1 (en) | Multiple analyte assay device | |
JP2000356638A (en) | Housing for immunochromatograph | |
US20020137231A1 (en) | Device for the collection, testing and shipment of body fluid samples | |
US20030232451A1 (en) | Device for the testing of fluid samples and process for making the device | |
GB2339616A (en) | Drug testing and sample transporting device | |
AU6301799A (en) | Device for the testing of body fluid samples | |
MXPA01000051A (en) | Device for the testing of fluid samples and process for making the device | |
MXPA97008669A (en) | Device for the collection, testing and shipment of body fluid samples | |
AU2003262462B2 (en) | Multiple analyte assay device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA CN DE GB HU IL JP KR MX NO NZ PL PT RU SG TR US US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref country code: GB Ref document number: 200028544 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref document number: 2334802 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 140230 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000923112 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/000051 Country of ref document: MX |
|
WWP | Wipo information: published in national office |
Ref document number: 2000923112 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000923112 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AU BR CA CN DE GB HU IL JP KR MX NO NZ PL PT RU SG TR US US |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-23, DESCRIPTION, REPLACED BY NEW PAGES 1-22; PAGES 24-28, CLAIMS, REPLACED BY NEW PAGES 23-27; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |